Key Highlights
- Arq reported first-quarter 2026 revenue of $29.1 million, up 7% year over year, but gross margin slipped to 34.2% and the company posted a net loss of $0.8 million.
- Independent testing showed the Red River GAC facility's thermal oxidizer can support only about 15 million pounds of annual output versus an original 25-million-pound design target, prompting a production pause and an optimization review due by the third quarter of 2026.
- The idled Corbin, Kentucky facility is now being tested as an asphalt additive and rare-earth source, with Arq in discussions on possible monetization.
- Utilities must complete initial PFAS drinking-water monitoring by 2027, but in May 2026 the EPA proposed extending compliance deadlines for two PFAS chemicals to 2031 while rescinding limits on three others.
Arq, Inc. (NASDAQ:ARQ) built a granular activated-carbon line at its Red River Plant to chase PFAS-driven clean-water demand, but design flaws capped output short of nameplate capacity. The company paused GAC production in March 2026, idled its Corbin facility, and expects no GAC output in fiscal 2026 while completing a strategic review due by the third quarter.
Why a Water-Treatment Supplier Is Back in Investors' Line of Sight
Arq, formerly Advanced Emissions Solutions, has spent the past two years repositioning from a mercury-control chemicals supplier tied to coal-fired power plants into a broader environmental technology company built around granular activated carbon (GAC), a filtration media increasingly required by municipal water systems to strip PFAS "forever chemicals," and its claim to be the only vertically integrated activated-carbon producer in North America.
The current attention is less about a smooth scale-up and more about a costly engineering setback. In its first-quarter 2026 results, released May 6, 2026, Arq disclosed it paused GAC production in March 2026 after testing showed the facility's thermal oxidizer could not support planned volumes. The near-term business is a profitable powdered-carbon operation sitting alongside a GAC project now under review rather than ramp-up.
Inside Arq's Activated-Carbon Business
Arq manufactures activated carbon and related chemicals that remove mercury, PFAS and other contaminants from air, water and soil, a market it calls "advanced purification technologies." Production is concentrated at the Red River Plant in Coushatta, Louisiana, fed by lignite from Arq's own Five Forks Mine. Arq also holds an idled facility in Corbin, Kentucky, capable of converting bituminous coal fines into a purified microfine powder it calls Corbin Wetcake. PAC, its historical revenue base, is sold to coal-fired generators for mercury control and to utilities for taste-and-odor treatment. In August 2025 the company commissioned a new GAC line at Red River aimed at the municipal water market expanded by federal PFAS rules.
The Catalyst for Arq, Inc. (ARQ): A GAC Reset, Not Yet a Scale-Up
The catalyst driving interest in Arq (ARQ) is a reset of the GAC growth plan, not a production ramp. Per the Form 10-Q, it became clear by December 2025 that reaching nameplate capacity would need further modifications due to design flaws in the GAC facility, compounded by Corbin Wetcake feedstock variability. Independent testing completed in January 2026 showed the thermal oxidizer could support roughly 15 million pounds of annual output, versus an original design of 25 million pounds or more, and that the smaller volume alone would not generate attractive returns.
In March 2026, Arq paused GAC production, continued idling Corbin as a cost-saving step, and launched an optimization review covering design modifications and production economics at different scales. It now intends to shift feedstock from Corbin Wetcake toward a bituminous "proven performance coal" believed to overcome the design constraints, and does not expect GAC production in fiscal 2026. Arq aims to finalize a go-forward strategy by the third quarter, and is litigating against the engineering firm that designed the facility for alleged negligence; that firm has countersued over its fees.
Latest Financial and Operational Performance
Arq's first-quarter 2026 revenue was $29.1 million, up from $27.2 million a year earlier, on higher sales volumes, partly offset by pricing mix. Gross margin was 34.2%, down from 36.4%, reflecting an inventory revaluation charge, carry-over GAC costs, and a lower-margin product mix. SG&A rose to $7.4 million from $6.1 million, largely on legal fees tied to the design-firm litigation. Arq posted an operating loss of $1.0 million versus operating income of $0.7 million a year earlier, and a net loss of $0.8 million, or $0.02 per diluted share, versus net income of $0.2 million in the first quarter of 2025. Adjusted EBITDA was $2.7 million, down from $4.1 million. Management said the March charge masked stronger underlying margins in January and February, reflecting a PAC business no longer bearing GAC's costs.
Revenue, Cash, Debt and Funding Position
Arq ended the quarter with $15.9 million of combined cash and restricted cash, including $11.2 million pledged mainly as collateral, up from $15.0 million at year-end 2025; unrestricted cash was $4.7 million. Total debt, including finance leases, was $30.2 million, up from $28.5 million, on higher borrowings under Arq's MidCap Financial revolver, which stood at $20.9 million. Capex fell to $0.7 million from $3.7 million as GAC construction wound down. In March 2026, Arq amended its revolver to replace a minimum-liquidity covenant with an availability-reserve requirement, and secured a covenant waiver from its term lender for fiscal 2025. Management expects cash on hand and revolver availability to fund operations for 12 months, and reaffirmed 2026 guidance of $120 million to $125 million in revenue and $17 million to $20 million in Adjusted EBITDA.
Growth Opportunities and Upcoming Milestones
Arq's roadmap centers on three tracks. First, the GAC review is due by the third quarter of 2026 with a costed plan for scale and capital needs. Second, Corbin is being tested as an asphalt additive, now advancing to small in-field trials, alongside rare-earth recovery work, with Arq in discussions on monetizing the facility. Third, PAC should keep growing on higher natural-gas prices and municipal demand. The federal PFAS rule remains a structural driver, though the EPA's May 2026 proposals to extend some deadlines and rescind other limits add uncertainty to the pace of GAC demand.
Material Company-Specific Risks
The most immediate risk is execution: Arq must fund a path to profitable GAC production after already absorbing a costly design failure, and may conclude further investment is unattractive. Litigation against its former design firm carries uncertain timing and outcome. Idled Corbin, PAC seasonality, customer concentration, and a revolver with renegotiated covenants add variability. Regulatory risk cuts both ways: EPA proposals to roll back parts of the PFAS rule could slow the demand Arq's GAC strategy needs.
Outlook
In an upside case, Arq's review yields a lower-capital GAC design with attractive returns, Corbin's asphalt and rare-earth work gains customers, and PAC keeps expanding as PFAS deadlines near. In a base case, PAC generates steady revenue while the GAC decision extends into 2027 and Corbin stays a call option. In a downside case, the review finds GAC economics unattractive at any scale, litigation drags on, and covenant-driven constraints limit flexibility. None of this should be read as a prediction of where shares will trade.
Conclusion
Arq, Inc. (ARQ) is navigating an engineering and strategic reset, not the clean production ramp its GAC ambitions once implied. Its PAC business remains profitable, its balance sheet retains revolver-backed liquidity, and PFAS regulation still points toward multi-year water-treatment demand. But turning Arq's carbon platform into a scaled GAC producer now runs through a design fix and a Q3 2026 review whose outcome is not yet known.
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.






Please wait processing your request...